Stockreport

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST [Yahoo! Finance]

Unity Biotechnology, Inc.  (UBX) 
Last unity biotechnology, inc. earnings: 3/11 04:05 pm Check Earnings Report
PDF novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key drug [Read more]